Drug Type Small molecule drug |
Synonyms 2,5-Cyclohexadiene-1,4-dione, 2,5-bis(1-aziridinyl)-3-(hydroxymethyl)-6-methyl-, NSC-697726, RH 1 |
Target |
Mechanism DNA inhibitors(DNA inhibitors), Apoptosis stimulants, DNA cross linking agents |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC12H14N2O3 |
InChIKeyJKDLOGLNPDVUCX-UHFFFAOYSA-N |
CAS Registry221635-42-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 1 | US | 01 Nov 2007 | |
Non-Hodgkin Lymphoma | Phase 1 | US | 01 Nov 2007 | |
Solid tumor | Phase 1 | US | 01 Nov 2007 | |
Non-Small Cell Lung Cancer | Phase 1 | - | - | |
Non-Small Cell Lung Cancer | Phase 1 | - | - | |
Non-Small Cell Lung Cancer | Phase 1 | - | - |